RML recalls 10 drug batches for seizure and cardiac treatments

Delhi's Rajendra Prasad Centre for Ophthalmic Sciences has announced the recall of ten batches of pharmaceutical products following quality control deficiencies identified during routine analytical testing. The recalled batches include three tablet formulations and five injectable preparations that failed analytical testing protocols, along with two additional batches found to have physical defects.

The medications targeted in the recall are used for the treatment of seizure disorders and cardiac conditions, medications commonly prescribed across Indian healthcare facilities. The centre's quality assurance department flagged these batches after they did not meet established pharmaceutical standards during routine quality checks.

According to the hospital's statement, no severe adverse effects or patient complications have been reported in connection with the affected batches to date. However, the institution has initiated the precautionary recall to ensure patient safety and maintain pharmaceutical integrity.

The recall highlights the importance of robust quality control mechanisms in pharmaceutical manufacturing and distribution. The hospital has advised healthcare providers who may have received these batches to halt their dispensing and ensure proper disposal according to regulatory guidelines. Patients currently using medications from the recalled batches are advised to consult their physicians for guidance on alternative treatments.